None of the discovered mutations have previously been reported in NB, leading us to conclude that the observed phenotypic changes in 17q1qMYCN were likely a product of the CNAs and MYCN overexpression rather than an expansion of new clonal cell populations with additional pathognomonic mutations. This evidence concerns the gene MYCN and neuroblastoma.